Literature DB >> 15036846

Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement.

Elizabeth J Adams1, David J Convery, Vivian P Cosgrove, Helen A McNair, John N Staffurth, Jaap Vaarkamp, Christopher M Nutting, Alan P Warrington, Steve Webb, Jan Balyckyi, David P Dearnaley.   

Abstract

BACKGROUND AND
PURPOSE: Two systems have been developed for treating patients with locally advanced prostate cancer using intensity-modulated radiotherapy (IMRT): one using dynamic multi-leaf collimator delivery and the other using step-and-shoot. This paper describes the clinical implementation of these two techniques, and presents results from the first 14 patients treated in a clinical setting (nine dynamic, five step-and-shoot). PATIENTS AND METHODS: Dynamic treatments were planned using Corvus, and step-and-shoot using Helax-TMS; all were delivered using Elekta accelerators. Prior to the first clinical treatments, validation measurements were carried out for each system, including measurements for a complete IMRT treatment. The reproducibility of dynamic delivery and the characteristics of the accelerator for low-monitor-unit (MU) deliveries were also assessed. An extensive quality assurance (QA) program was performed for each of the patients. Additionally, timing measurements were carried out to assess the practicalities of the technique.
RESULTS: The planning objectives were met in most cases. Absolute doses for complete IMRT treatments were within 2%, on average, with dose distributions generally showing agreement within 3% or 3 mm. Beam modulation measurements made throughout each patient's treatment indicated that both delivery methods were reproducible. The dynamic plans required an average of 765 MU per beam, with a treatment delivery time of 14 min; corresponding results for step-and-shoot plans were 105 MU and 10 min.
CONCLUSIONS: Two IMRT techniques for this group of patients have been successfully implemented in the clinic. The more complex dynamic treatments showed no advantages over the step-and-shoot approach. QA results have shown accurate and reproducible delivery for both techniques, giving increased confidence in the techniques and allowing a reduction in the QA program.

Entities:  

Mesh:

Year:  2004        PMID: 15036846     DOI: 10.1016/j.radonc.2003.09.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization.

Authors:  Marius Treutwein; Matthias Hipp; Oliver Kölbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

3.  Dosimetric and physical comparison of IMRT and CyberKnife plans in the treatment of localized prostate cancer.

Authors:  Cemile Ceylan; Nadir Kucuk; Hande Bas Ayata; Metin Guden; Kayihan Engin
Journal:  Rep Pract Oncol Radiother       Date:  2010-11-12

4.  Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer.

Authors:  Marius Treutwein; Matthias Hipp; Oliver Koelbl; Barbara Dobler
Journal:  Radiat Oncol       Date:  2012-07-11       Impact factor: 3.481

5.  Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the Montpellier Comprehensive Cancer Center.

Authors:  Pascal Fenoglietto; Benoit Laliberté; Norbert Aillères; Olivier Riou; Jean-Bernard Dubois; David Azria
Journal:  Radiat Oncol       Date:  2011-07-20       Impact factor: 3.481

6.  Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.

Authors:  Ute Ganswindt; Frank Paulsen; Stefan Corvin; Kai Eichhorn; Stefan Glocker; Ilse Hundt; Mattias Birkner; Markus Alber; Aristotelis Anastasiadis; Arnulf Stenzl; Roland Bares; Wilfried Budach; Michael Bamberg; Claus Belka
Journal:  BMC Cancer       Date:  2005-07-28       Impact factor: 4.430

7.  Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.

Authors:  Miguel Reis Ferreira; Atia Khan; Karen Thomas; Lesley Truelove; Helen McNair; Annie Gao; Chris C Parker; Robert Huddart; Margaret Bidmead; Ros Eeles; Vincent Khoo; Nicholas J van As; Vibeke N Hansen; David P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-02       Impact factor: 7.038

8.  Twin machines validation for VMAT treatments using electronic portal-imaging device: a multicenter study.

Authors:  P Fenoglietto; M Khodri; D Nguyen; F Josserand-Pietri; N Aillères
Journal:  Radiat Oncol       Date:  2016-01-14       Impact factor: 3.481

9.  Treatments of exceptionally large prostate cancer patients with low-energy intensity-modulated photons.

Authors:  Mei Sun; Lijun Ma
Journal:  J Appl Clin Med Phys       Date:  2006-11-28       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.